MIND Diet Intervention for Cognitive Function in Breast Cancer Patients

This study is exploring if the MIND diet can help women with breast cancer who are undergoing active treatment. Many women experience memory and thinking problems during and after breast cancer treatment. The MIND diet is rich in anti-inflammatory foods and has shown promise in protecting brain function. Participants will either receive nutrition counseling on the MIND diet or general health education. Researchers will measure changes in your memory and thinking skills to see if the MIND diet helps. This study is for women aged 45-75 with Stage II-IV hormone receptor positive breast cancer who are post-menopausal and starting systemic therapies.

Study design
This is an interventional study planning to enroll 43 women. Participants will be assigned to either the MIND Diet Intervention Group or the General Health Curriculum Group.
What's involved
You would attend 8 sessions over 12 weeks, either for nutrition counseling or general health topics. You will also complete questionnaires and assessments at the end of the sessions and 6 months later.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed up 6 months after completing the 12-week intervention sessions.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05984888

Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer

Recruiting
NAAges 45–75InterventionalPrevention
Ohio State University Comprehensive Cancer Center
~43 participants
Updated 2025-10-03 on ClinicalTrials.gov
What's tested:MIND Diet Intervention GroupGeneral Health Curriculum (GHC) Group

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Remote Assessment of Cognition using the Hopkins Verbal Learning Test (HVLT)
Measured over One day
+3 more outcomes measured
Breast Cancer
1 sites across 1 states
Ohio1
  • Tonya S Orchard, PhD · PRINCIPAL_INVESTIGATOR · Ohio State University
The Ohio State University Comprehensive Cancer Center
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Stage II-IV hormone receptor+, breast cancer diagnosis
Post-menopausal (defined as at least 1-year post menses, on ovarian suppression medication, or s/p oophorectomy)
Within 4 weeks before or 12 weeks after starting initial systemic therapies (e.g. chemotherapy, targeted therapies such as CDK4/6 inhibitors, endocrine therapy)
Ability to access and use internet resources, including video calls using Zoom platform
English speaking

Exclusion

History of dementia, stroke, traumatic brain injury, brain metastasis or other conditions that could lead to cognitive impairment
MIND diet score \>8
Unwilling/unable to eat \>2 types of MIND food
Receiving insulin therapy for diabetes
Diagnosis of triple negative breast cancer
Unable to give informed consent.
  • Remote Assessment of Cognition using the Hopkins Verbal Learning Test (HVLT)One day

    Assess cognition remotely through a Zoom session by using the Hopkins Verbal Learning Test (HVLT), a brief cognitive test of episodic memory and verbal learning. The HVLT is broken down into three trials of free-recall from a 12-item list of words, followed by a period of time then a fourth recall trial. Finally, the test ends with a recognition task. For all trials, the maximum score is 12 with higher scores indicating better cognition.

  • Remote assessment of cognition using the WAIS-IV Digit SpanOne day

    Assess cognition remotely through a Zoom session by using the Wechsler Adult Intelligence Scale (WAIS)-IV Digit Span, a cognitive test of attention and working memory. The WAIS-IV Digit Span is comprised of three individual tests: Digit Span Forward, Digit Span Backward, and Digit Span Sequence. A total potential score of 48 with higher scores indicating better cognition.

  • Remote assessment of cognition using the Oral Trail Making TestOne day

    Assess cognition remotely through a Zoom session by using the Oral Trail Making Test (TMT), a brief cognitive test of executive function and attention. The OTMT is divided into part A and part B. The part A asks participants to count from 1-25, while part B asks participants to alternate between letters and numbers. The less amount of time required to complete the task equates to better cognition.

  • Remote assessment of cognition using the COWA TestOne day

    Assess cognition remotely through a Zoom session by using the Controlled Oral Word Association (COWA) Test, a brief cognitive test of oral fluency and executive function. The COWAT has two components, the first asks the participants to say as many words as possible that begin with a given letter (F, A, or S) within the one-minute time frame. The second trial asks the same task but instead of letters, the participant is asked to produce as many animals as possible within the provided time frame. More words produced are indicative of better cognitive function.